Search
Search
Close this search box.

Flora Growth meets Colombian senator as recreational bill introduced

Home » Flora Growth meets Colombian senator as recreational bill introduced

Global cannabis manufacturer and distributor, Flora Growth has met with the author of a new bill to legalise recreational cannabis on the day the legislation was introduced to Congress.

Flora’s Chairman and CEO Luis Merchan met with Colombian Senator Gustavo Bolivar prior to the bill’s introduction to Congress on July 20. 

Bolivar, the key author of the bill, and Merchan discussed the top tenants of the bill, the bill’s implications for companies such as Flora in Colombia and what legalisation means for the country’s burgeoning domestic and international cannabis markets. 

Read more: Colombia votes in pro-cannabis president Gustavo Petro

Colombia recently voted in pro-cannabis president, Gustavo Petro, who has expressed his desire for the country to become a leader in the legal cannabis industry. 

Cannabis for personal use is currently decriminalised in Colombia while medical cannabis was legalised in 2015. The proposed cannabis legalisation bill will allow full recreational cannabis legalisation in Colombia, building on resolutions and regulations that are important for the safe development and access of the legal cannabis industry, including oversight by INVIMA.

Read more: Flora Growth steps up international growth strategy with opening of offices in London

Flora Growth CEO, Luis Merchan commented: “We are honoured to work closely with Sen. Bolivar and other key policymakers to support legislation that will provide safe access to cannabinoid-based products both domestically and in international markets.

“We are committed to creating effective, high-quality products. And with the expectation of the passing of this new bill to legalise recreational cannabis, we seek to support further the communities in which we operate.”

Highlights of the discussion include:

  • Highlights a flourishing cannabis industry in Colombia, including both domestic trade and international exports
  • The future of cannabis regulations, including the potential of a new government entity solely focused on cannabis regulation
  • Cannabis pharmaceuticals and the need for government regulations and approvals
  • Colombia as an upcoming global leader in the legal export of cannabis and its derivatives

Watch the video of the discussion:

[activecampaign form=31]

🔒 Risk Management Report • Produced in partnership with RELM
Prohibition Partners RELM
📊 New Report Available Now

Relm Risk Briefing: Cannabis 2026

The global cannabis sector has moved from experiment to enterprise. This comprehensive risk briefing examines how regulation, insurance, and operational practices intersect across the international supply chain, drawing on insights from RELM—the only insurer entirely dedicated to the cannabis industry.

What's covered

  • 🌱 Cultivation risk management — biological contamination, environmental instability, and security protocols
  • ⚗️ Manufacturing & extraction — GMP standards, in-house testing, and quality control measures
  • 🔬 Testing & compliance — rigorous protocols ensuring product safety and regulatory adherence
  • 📦 Distribution & logistics — GDP-aligned transport, route monitoring, and cargo insurance
Key focus areas
Cultivation Manufacturing Testing & QC Packaging Distribution Retail & Pharmacy
100% free • Comprehensive risk analysis

Key insights

Industry Maturity Cannabis has evolved from patchwork markets to international enterprise, with risk management now the measure of long-term stability.
Cultivation Challenges Operators addressing biological contamination through controlled-environment agriculture, tissue culture, and IPM protocols.
Quality Control GMP adherence, in-house testing, and selective supplier relationships emerging as critical control points.
Supply Chain Security GDP-aligned transport, route monitoring, and comprehensive insurance remain essential safeguards.
Market Access Initiatives stabilizing domestic supply and expanding pharmacy training improving patient and consumer access.
Produced by Prohibition Partners in collaboration with RELM—the only insurer dedicated to emerging industries like cannabis.
Partnership
Produced by Prohibition Partners in collaboration with RELM

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?